Central nervous system involvement as the presenting manifestation of autoimmune rheumatic diseases: An observational study using the American College of Rheumatology nomenclature for neuropsychiatric lupus

Clinical and Experimental Rheumatology

Volumn 24, Issue 6, 2006, Pages 629-635

  Mastorodemos, Vasileios ^a   Mamoulaki, Marilena ^a   Kritikos, Herakles ^a   Plaitakis, Andreas ^a   Boumpas, Dimitrios T ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Antiphospholipid syndrome; Cerebrovascular disease; Initial; Neuropsychiatric disease

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1 ANTIBODY; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LA ANTIBODY; LUPUS ANTICOAGULANT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; RHEUMATOID FACTOR; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; SM ANTIBODY; STEROID; THROMBOPLASTIN;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; BLOOD ANALYSIS; BLOOD CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CHOREA; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOPPLER ECHOGRAPHY; ELECTROCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GREECE; HEADACHE; HEALTH CARE ORGANIZATION; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; MALE; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; RHEUMATIC DISEASE; SEIZURE; SPINAL CORD DISEASE; SYMPTOM; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC VASCULITIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; BRAIN DISEASES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; TERMINOLOGY; VASCULITIS;

EID: 33846441643     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BOUMPAS DT, AUSTIN HA 3RD, FESSLER BJ, BALOW JE, KLIPPEL JH, LOCKSHIN MD: Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematological disease. Ann Intern Med 1995; 122: 940-50.
2. NADEAU SE: Neurologic manifestations of systemic vasculitis. Neurol Clin 2002; 20: 123-50.
3. ANTUNES MC, D'CRUZ D, HUGHES GR: Neurological manifestations of anti-phospholipid (Hughes) syndrome. Clin Exp Rheumatol 2004; 22: 771-5
4. KARLSON EW, SANCHEZ-GUERRERO J, WRIGHT EA et al.: A Connective Tissue Disease Screening Questionnaire for Population Studies. Ann Epiderniol 1995; 5: 297-302.
5. BRANDT JT, TRIPLETT DA, ALVING B, SCHARRER I: Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-90.
6. HUNDER GG, AREND WP, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33: 1065-144.
7. LEAVITT RY, FAUCI AS, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33: 1101-7.
8. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-77.
9. WILSON WA, GHARAVI AE, KOIKE T et al.: International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11.
10. ASHERSON RA, CERVERA R, DE GROOT P et al.: Catastrophic antiphospholipid syndrome (CAPS): International consensus statement on classification criteria and treatment guidelines. Lupus 2003; 12: 530-4.
11. ACR ad hoc Committee on neuropsychiatric lupus nomenclature: The American College of Rheumatology and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
12. BOUMPAS DT, YAMADA H, PATRONAS NJ, SCOTT D, KLIPPEL JH, BALOW JE: Pulse cyclophosphamide for severe neuropsychiatric lupus. Q JMed 1991; 81: 975-84.
13. BOUMPAS DT, KRITIKOS HD, DASKALAKIS NG: Perspective on future therapy of vasculitis. Curr Rheumatol Rep 2000; 2: 423-9.
14. BOUMPAS DT: Sequential therapies with intravenous cyclophosphamide and oral mycophenolate mofetil or azathioprine are efficacious and safe in proliferative lupus nephritis. (Commentary). Clin Exp Rheumatol 2004; 22: 276-7
15. CERVERA R, ASHERSON RA, FONT J et al.: Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997; 76: 203-12.
16. BREY RL, HOLLIDAY SL, SAKLAD AR et al.: Neuropsychiatric syndromes in lupus. Prevalence using standardized definitions Neurology 2002; 58: 1214-20.
17. AINIALA H, LOUKKOLA J, PELTOLA J, KORPELA M, AND HIETAHARJU A: The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001; 57: 496-500.
18. AFELTRA A, GARZIA P, MITTERHOFER AM et al.: Neuropsychiatric lupus syndromes Relationship with antiphospholipid antibodies Neurology 2003; 61: 108-11.
19. SANNA G, BERTOLACCINI ML, CUADRADO MJ et al.: Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-92.
20. CERVERA R, PIETTE JC, FONT J et al.: Antiphospholipid Syndrome Clinical and Immunologic Manifestations and Patterns of Disease Expression in a Cohort of 1,000 Patients. Arthritis Rheum 2002; 46: 1019-27.
21. GALLI M, LUCIANI D, BERTOLINI G AND BARBUI T: Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32.
22. KHAMASHTA MA, CUADRADO MJ, MUJIC F, TAUB NA, HUNT BJ, HUGHES GR: The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-7.
23. CROWTHER MA, GINSBERG JS, JULIAN J et al.: A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med 2003; 349: 1133-8.